There Go the Biotechs as Generic Approval Rocks Amgen

By Ben LevisohnBiotech stocks like Gilead Sciences (GILD) and Amgen (AMGN) have been a great place to be for investors. Now, the approval of the first biosimilar in the U.S. is raising concerns that biotech profits will decline–and causing their stocks to tumble. Citigroup’s Andrew Baum and team explain why:
Bloomberg News

Approval of Sandoz’s Zarxio, with full extrapolation across indications and lack […]

HOSPIRA INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders

moreView todays social media effects on HSPView the latest stocks trending across Twitter. Click to view dashboardSee who Hospira is hiring next, click here to view […]

HOSPIRA INC Financials

moreView todays social media effects on HSPView the latest stocks trending across Twitter. Click to view dashboardSee who Hospira is hiring next, click here to view […]

Hospira Convenes Its 2014 Annual Meeting of Shareholders

[PR Newswire] – LAKE FOREST, Ill., May 7, 2014 /PRNewswire/ — Hospira, Inc. (NYSE: HSP), the world’s leading provider of injectable drugs and infusion technologies, today held its 2014 Annual Meeting of Shareholders … moreView todays social media effects on HSPView the latest stocks trending across Twitter. Click to view dashboardSee who Hospira is hiring next, click here to view […]

Botched execution adds to US death penalty alarm

[at Financial Times] – A botched US execution led to the drawn-out death of a prisoner from a heart attack after the procedure to kill him using a controversial set of lethal drugs was halted as he writhed on a gurney. The execution … moreView todays social media effects on HSPView the latest stocks trending across Twitter. Click to view […]

[video] Stock Pops & Drops: WBMD, GOGO, HSP

moreView todays social media effects on HSPView the latest stocks trending across Twitter. Click to view dashboardSee who Hospira is hiring next, click here to view […]

Hospira agrees to $60 mln settlement over quality control problems

moreView todays social media effects on HSPView the latest stocks trending across Twitter. Click to view dashboardSee who Hospira is hiring next, click here to view […]

Fitch Affirms at Sanofi SA at ‘AA-‘; Outlook Stable

[Reuters] – Fitch Ratings has affirmed France-based healthcare company Sanofi SA’s (Sanofi) Long-term Issuer Default Rating (IDR) and senior unsecured rating at ‘AA-‘ and its Short-term IDR at ‘F1+. The affirmation reflects Sanofi’s ability to weather th moreView todays social media effects on HSPView the latest stocks trending across Twitter. Click to view dashboardSee who Hospira is hiring next, click […]

Update-Moody’s: AbbVie, Amgen and Roche most exposed to biosimilar drugs market

[Reuters] – Biosimilar drugs market moreView todays social media effects on HSPView the latest stocks trending across Twitter. Click to view dashboardSee who Hospira is hiring next, click here to view […]

Will Hospira’s Lack of a Dividend Hold It Back in 2014?

moreView todays social media effects on HSPView the latest stocks trending across Twitter. Click to view dashboardSee who Hospira is hiring next, click here to view […]